Emergence of omentin as a pleiotropic adipocytokine

Experimental and Clinical Endocrinology and Diabetes

Volumn 121, Issue 7, 2013, Pages 377-383

  Jaikanth, C ^a   Gurumurthy, P ^a   Cherian, K M ^a   Indhumathi, T ^b  

^a Dr KM Cherian Heart Foundation   (India)

^b Medical Officer   (India)

Author keywords

adipocytokine; cardiovascular diseases; metabolism; omentin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APELIN; CHEMERIN; COMPLEMENT FACTOR D; CYCLOOXYGENASE 2; ESTROGEN; GLUCOSE TRANSPORTER 4; INSULIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LECTIN; LEPTIN; LIRAGLUTIDE; METFORMIN; NORADRENALIN; OMENTIN 1; OMENTIN RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; PIOGLITAZONE; PROTEIN P21; PROTEIN P53; RESISTIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASPIN;

ADIPOSE TISSUE; AEROBIC EXERCISE; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BONE DENSITY; BONE METABOLISM; CANCER GROWTH; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DEPRESSION; ENDOTHELIAL DYSFUNCTION; ESTROGEN BLOOD LEVEL; FEEDING BEHAVIOR; FEMUR NECK; FLUID INTAKE; FOOD INTAKE; HEART PROTECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; METABOLIC SYNDROME X; MULTIPLE MYELOMA; NONHUMAN; OBESITY; OSTEOLYSIS; PANDEMIC; PLEURA MESOTHELIOMA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; UROGENITAL SYSTEM;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASES; CYTOKINES; DIABETES MELLITUS; GPI-LINKED PROTEINS; HUMANS; INSULIN RESISTANCE; LECTINS; METABOLIC SYNDROME X; OBESITY;

EID: 84880071766     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0033-1345123     Document Type: Review

References (61)

1. Hamdy O. The role of adipose tissue as an endocrine gland. Curr Diab Rep: 2005; 5 317 319 (Pubitemid 41600772)
2. Xu Y. R., Hu P., Jadhao H. et al. Cloning of omentin, a new adipocytokine from omental fat tissue in humans. Diabetes: 2003; (Suppl 1): A1
3. Fu M., Gong D. W., Damcott C. et al. Systematic analysis of omentin 1 and omentin 2 on 1q23 as candidate genes for type 2 diabetes in the old order amish. Diabetes: 2004; 53 59
4. St Jean P., Husueh W. C., Mitchell B. et al. Association between diabetes, obesity, glucose and insulin levels in the old older amish and SNPs on 1q21-23. Am J Hum Genet: 2000; 67 332 337
5. Xiang K., Wang Y., Zheng T. et al. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21- q24. Diabetes: 2004; 53 228 234 (Pubitemid 38044720)
6. Fain J. N., Sacks H. S., Buehrer B. et al. Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int J Obes: 2008; 32 810 815 (Pubitemid 351670615)
7. Schaffler A., Neumeier M., Herfarth H. et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta: 2005; 1732 96 102 (Pubitemid 43267310)
8. Komiya T., Tanigawa Y., Hirohashi S. Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice. Biochem Biophys Res Commun: 1998; 251 759 762 (Pubitemid 28512784)
9. Senolt L., Polanská M., Filková M. et al. Vaspin and Omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis: 2010; 69 1410 1411
10. Xu L., Zhu G. B., Wang L. et al. Synovial fluid omentin-1 levels are inversely correlated with radiographic severity of knee osteoarthritis. J Investig Med: 2012; 60 583 586
11. Schäffler A., Neumeier M., Herfarth H. et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta: 2005; 1732 96 102 (Pubitemid 43267310)
12. Tanaka K. Expression of Toll-like receptors in the intestinal mucosa of patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol: 2008; 2 193 196
13. Kuperman D. A. Dissecting asthma using focused transgenic modeling and functional genomics. J Allergy Clin Immunol: 2005; 116 305 311 (Pubitemid 41096536)
14. Ismail S. A., Mohamed S. A. Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity. Br J Dermatol: 2012; 167 436 439
15. Xue Y., Jiang L., Cheng Q. et al. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. PLoS One: 2012; 7 e46740
16. Fioravanti L., Simonini A., Cantarini G. et al. Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease. Pediatr Rheumatol Online J: 2011; 9 304
17. Kazama K., Usui T., Okada M. et al. Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol: 2012; 686 116 123
18. Yamawaki H., Kuramoto J., Kameshima S. et al. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun: 2011; 408 339 343
19. Akbarzadeh S., Ghasemi S., Kalantarhormozi M. et al. Relationship among plasma adipokines, insulin and androgens level as well as biochemical glycemic and lipidemic markers with incidence of PCOS in women with normal BMI. Gynecol Endocrinol: 2012; 28 521 524
20. Tan B. K., Adya R., Farhatullah S. et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes: 2008; 57 801 808
21. Tan B. K., Adya R., Farhatullah S. Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes: 2010; 59 3023 3031
22. Yang R. Z., Lee M. J., Hu H. et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. AJP Endo: 2006; 290 1253 1261
23. Moreno-Navarretel J. M., Ortegal F., Castro A. Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity: 2011; 19 1552 1559
24. Wurm S., Neumeier M., Weigert J. et al. Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults. Cardiovascular Diabetology: 2007; 6 7
25. Devaraj S., Dasu M. R., Park S. H. et al. Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia: 2009; 52 1665 1668
26. Esteghamati A., Noshad S., Rabizadeh S. et al. Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial. Regul Pept: 2013; 182C 1 6
27. Bingley P. J., Mahon J. L., Gale EA M. Insulin Resistance and Progression to Type 1 Diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care: 2008; 31 146 150
28. Tan B. K., Pua S., Syed F. Decreased plasma omentin-1 levels in Type 1 diabetes mellitus. Diabet Med: 2008; 25 1254 1255
29. De Souza Batista C. M., Yang R. Z., Lee M. J. et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes: 2007; 56 1655 1661 (Pubitemid 46842600)
30. Yan P., Li L., Yang M. et al. Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract: 2011; 92 368 374
31. Yilmaz Y., Yonal O., Kurt R. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand J Gastroenterol: 2011; 46 91 97
32. Wali A., Morin P. J., Hough C. D. et al. Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE). Lung Cancer: 2005; 48 19 29 (Pubitemid 40380997)
33. Washimi K., Yokose T., Yamashita M. et al. Specific expression of human intelectin-1 in malignant pleural mesothelioma and gastrointestinal goblet cells. PLoS One: 2012; 7 e39889
34. Lago F., Dieguez C., Gomez-Reino J. et al. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol: 2007; 3 716 724 (Pubitemid 350187017)
35. Zhang Y. Y., Zhou L. M. Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells. Eur J Pharmacol: 2012; 12 947 948
36. Fowler J. A., Lwin S. T., Drake M. T. et al. Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease. Blood: 2011; 118 5872 5882
37. Gualillo O., González-Juanatey J. R., Lago F. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. Trends Cardiovasc Med: 2007; 17 275 283 (Pubitemid 350087698)
38. Brand K., Page S., Walli A. K. Physiological society symposium: impaired endothelial and smooth muscle cell function in oxidative stress. Experimental physiology: 1997; 82 297 304
39. Meigs J. B., Hu F. B., Rifai N. et al. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA: 2004; 291 1978 1986 (Pubitemid 38544279)
40. Oishi Y., Wakatsuki T., Nishikado A. et al. Circulating adhesion molecules and severity of coronary atherosclerosis. Coron Artery Dis: 2000; 11 77 81 (Pubitemid 30142724)
41. Zhong X., Li X., Liu F. et al. Omentin inhibits TNF-a-induced expression of adhesion molecules in endothelial cells via ERK/NF-KB pathway. Biochemical and Biophysical Research Communications: 2012; 425 401 406
42. Maruyama S., Shibata R., Kikuchi R. et al. Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism. J Biol Chem: 2012; 287 408 417
43. Whiteman E. L., Cho H., Birnbaum M. J. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab: 2002; 13 444 451 (Pubitemid 36733939)
44. Shiojima I., Walsh K. Role of Akt Signaling in Vascular Homeostasis and Angiogenesis. Circulation Research: 2002; 90 1243 1250 (Pubitemid 34787405)
45. Yamawaki H., Tsubaki N., Mukohda M. et al. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun: 2010; 393 668 672
46. Xie H., Xie P. L., Wu X. P. et al. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. Cardiovasc Res: 2011; 92 296 306
47. Moreno-Navarrete J. M., Ortega F., Castro A. et al. Circulating Omentin as a Novel Biomarker of Endothelial Dysfunction. Obesity: 2011; 19 1552 1559
48. Yoo H. J., Hwang S. Y., Hong H. C. et al. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol: 2012; 10 103
49. Cai R. C., Wei L., Di J. Z. et al. Expression of omentin in adipose tissues in obese and type 2 diabetic patients. Zhonghua Yi Xue Za Zhi: 2009; 89 381 384
50. El-Mesallamy H. O., El-Derany M. O., Hamdy N. M. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med: 2011; 28 1194 1200
51. Zhong X., Zhang H. Y., Tan H. et al. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin: 2011; 32 873 878
52. Shibata R., Ouchi N., Kikuchi R. et al. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis: 2011; 219 811 814
53. Saremi A., Asghari M., Ghorbani A. Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. Journal of Sports Sciences: 2010; 28 993 998
54. Alcelik A., Tosun M., Ozlu M. F. et al. Serum Levels of Omentin in End-Stage Renal Disease Patients. Kidney Blood Press Res: 2012; 35 511 516
55. Shelton R. C., Miller A. H. Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol: 2010; 91 275 299
56. Assadi M., Salimipour H., Akbarzadeh S. et al. Correlation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissue. PLoS One: 2011; 6 e24240
57. Brunetti L., Di Nisio C., Recinella L. et al. Effects of vaspin, chemerin and omentin-1 on feeding behavior and hypothalamic peptide gene expression in the rat. Peptides: 2011; 32 1866 1871
58. Barker G., Lim R., Georgiou H. M. et al. Omentin-1 is decreased in maternal plasma, placenta and adipose tissue of women with pre-existing obesity. PLoS One: 2012; 7 e42943
59. Yamauchi T., Kamon J., Ito Y. et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature: 2003; 423 762 769 (Pubitemid 36735700)
60. Takeuchi T., Adachi Y., Ohtsuki Y. et al. Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol: 2007; 40 115 120 (Pubitemid 47415941)
61. Yoshimura T., Oppenheim J. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties. Exp Cell Res: 2011; 317 674 684